LETTER TO THE EDITOR

Is transcatheter aortic valve implantation feasible in patients with chronic kidney disease?

EuroIntervention 2019;14:1791. DOI: 10.4244/EIJ-D-18-00500L

Rajkumar Doshi
Rajkumar Doshi1*, MD, MPH; Jay Shah2, MD
1. Department of Internal Medicine, University of Nevada, Reno School of Medicine, Reno, NV, USA; 2. Department of Internal Medicine, Mercy Saint Vincent Hospital, Toledo, OH, USA


We read the article “Transcatheter aortic valve implantation versus conservative treatment in chronic kidney disease patients.” by Steinmetz et al1 with great interest. This is a “non-randomised” and “single-centre” study. The authors compared transcatheter aortic valve implantation (TAVI) to conservative medical therapy in stage 3-5 chronic kidney disease (CKD) patients. They demonstrated that TAVI is associated with improved survival at one year compared to conservative therapy. This study is of vital importance as many of the physicians are hesitant to refer advanced stage CKD patients for TAVI as the data have been conflicting in previous studies. We agree that ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Reply to the letter to the editor “Is transcatheter aortic valve implantation feasible in patients with chronic kidney disease?”

Latest news